Corrections: July 23, 2025
An article on Monday about the biotech company Sarepta Therapeutics and its distribution of a treatment for a deadly muscle-wasting disease misstated the date that Sarepta halted shipments of Elevidys for non-ambulatory Duchenne patients. Shipments were halted on June 15, not July 15.
An article on Tuesday about President Trump urging two professional sports teams to change their names misstated the number of carved figures, known as the Guardians of Traffic, on the Hope Memorial Bridge in Cleveland. There are eight, not two.
An obituary on Tuesday about the actor Kenneth Colley misstated the cause of the character Admiral Piett's death in the movie 'Return of the Jedi.' His ship crashes into the Death Star; he is not shot down by a Rebel fighter.
Errors are corrected during the press run whenever possible, so some errors noted here may not have appeared in all editions.
To contact the newsroom regarding correction requests, please email nytnews@nytimes.com. To share feedback, please visit nytimes.com/readerfeedback.
Comments on opinion articles may be emailed to letters@nytimes.com.
For newspaper delivery questions: 1-800-NYTIMES (1-800-698-4637) or email customercare@nytimes.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Continuous glucose monitors are in vogue. But do you really need to track your blood sugar?
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, small patches that provide 24-hour insight into concentrations of sugar in the blood, could be a tool for Americans to 'take control over their own health,' Health Secretary Robert F. Kennedy Jr. recently told federal lawmakers. 'They can take responsibility,' Kennedy said. 'They can begin to make good judgments about their diet, about their physical activity, about the way they live their lives.' The devices have lifesaving benefits for people with diabetes, the disease caused when blood sugar remains high because their bodies don't make enough insulin or become resistant to it. The condition, which affects more than 38 million people in the U.S., raises the risk of serious health problems such as heart and kidney disease and vision loss. But the devices have surged in popularity among people without diabetes. Sales have been driven by high-profile marketers such as Casey Means, the nominee for U.S. surgeon general. There's scant evidence the monitors are useful for people with normal blood sugar levels, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Healthy bodies can effectively regulate glucose after meals and provide the energy they need to function. Glucose monitors may lead people to misinterpret normal swings in blood sugar that happen after eating or activity. In addition, the devices can be 'notoriously inaccurate,' providing misleading readings, she said. 'The problem with wearing these is that you can just be zooming in on and creating pathology when it's not there,' Dushay said. Here's what you need to know about the devices: Here's what a continuous glucose monitor does The device is a small patch, about the size of two stacked quarters, usually placed on the upper arm or stomach. It uses a needle to painlessly pierce the skin for a tiny sensor. The sensor measures the glucose in fluid under the skin, delivering a signal every few minutes to a phone app or a handheld display. The apps typically record blood sugar levels and help people track the foods they eat and how they impact those levels. When healthy people eat a meal that contains carbohydrates, their blood sugar rises, peaks and falls in response to the food. A healthy fasting blood glucose level for a person without diabetes is roughly 70 milligrams per deciliter to 99 milligrams per deciliter. A range from 100 to 126 milligrams per deciliter indicates prediabetes and above 126 milligrams per deciliter indicates diabetes, according to the American Diabetes Association. In adults without diabetes, blood sugar levels can climb to 140 milligrams per deciliter or more within an hour of a meal, before falling back to baseline levels within two or three hours, according to the association. It's a sign the body is processing sugar normally. Continuous glucose monitors have been available since the late 1990s For decades, these devices were available only for people with diabetes. The monitors revolutionized care by allowing more precise adjustment of insulin used to treat diabetes and giving people the ability to modify meals and activity more accurately. Last year, the U.S. Food and Drug Administration approved the first over-the-counter monitors. Since then, many companies have emerged to market them, claiming to provide intensive, individualized health monitoring. Cost is generally about $100 a month. They've really caught on with consumers curious about how food and activity affect their blood sugar levels. For instance, Noom, the weight-loss and fitness app, launched a blood glucose feature last year that has proven extremely popular, said Alexander Fabry, a company executive. 'Of the people who are using a CGM, the vast majority of them don't have a diabetes diagnosis,' he said. Who can use the monitors? The devices have been lifesaving for people with diabetes. And they can be helpful for people with risk factors for the disease, including obesity, prediabetes, a history of gestational diabetes or a family history of the condition. The devices can allow users to see how specific food and activity choices affect their blood sugar in near real-time, said Dr. Alaina Vidmar, a pediatric obesity specialist at Children's Hospital Los Angeles. 'After a large meal, you may watch your blood sugar go up and sort of learn something about yourself,' Vidmar said. 'For example, I drink a sugar-sweetened soda and my blood sugar goes up really high, really fast. And maybe I don't feel as good, right?' What are the cautions? People without risk factors for diabetes may turn to the monitors just because they're curious, said Dr. David Kessler. A former FDA commissioner, Kessler doesn't have diabetes, but he wore a monitor for a couple months during research for his recent book, 'Diet, Drugs and Dopamine.' 'I think it's a very interesting tool to experiment with if you're so inclined,' Kessler said. But, he noted, the devices can't be used to diagnose or treat disease. Even experts don't agree on how to interpret or provide health advice for people without diabetes based on blood sugar data. 'No one knows what's optimal in the nondiabetic state,' he said. Before using a monitor, Dushay asks patients to consider their motives. 'What do you think you're going to get from the data?' she said. 'What is to be gained from wearing that monitor?' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Jonel Aleccia, The Associated Press Sign in to access your portfolio
Fox News
31 minutes ago
- Fox News
Texas man sues California doctor in unprecedented abortion pill case over unborn child's alleged ‘murder'
A Texas man has filed a landmark federal wrongful death lawsuit against a California abortion provider, alleging the physician "murdered" his unborn children by mailing abortion pills across state lines. The case, Rodriguez v. Coeytaux, marks the first of its kind to test how far pro-life litigants can go to sidestep blue state abortion shield laws using century-old federal statutes and Texas civil code. Filed July 20 in the Southern District of Texas, the lawsuit accuses Dr. Remy Coeytaux of aiding illegal self-managed abortions in 2024, by mailing abortion-inducing drugs to Galveston County, Texas, where they were allegedly used to end two pregnancies. Plaintiff Jerry Rodriguez claims his girlfriend's estranged husband purchased the pills from Coeytaux through a Venmo transaction and pressured her to take them, ending two pregnancies Rodriguez says were his. At the heart of the suit is an alleged $150 Venmo payment to "Remy Coeytaux MD PC" labeled "Aed axes," followed by his girlfriend's name. The lawsuit states Rodriguez interprets "Aed axes" to be a phonetic spelling of "Aid Access," a network that helps women obtain abortion pills. Rodriguez alleges the first abortion occurred in September 2024, at the home of his girlfriend's mother, and the second in January 2025, at the home of her estranged husband. Ultrasound images from January, attached as Exhibit 2, are offered as proof of a second pregnancy. According to the complaint, the baby was a boy. Rodriguez is seeking over $75,000 in damages, certification of a national class of "fathers of unborn children," and a permanent injunction barring Coeytaux from mailing abortion drugs in violation of state or federal law. The complaint's legal foundation has drawn attention. The lawsuit revives the long-dormant Comstock Act, an 1873 federal anti-obscenity law banning the mailing of abortion-related materials. Though unenforced for over a century, the Comstock Act remains on the books. Jonathan Mitchell, the attorney behind Texas's heartbeat law (SB8), represents Rodriguez in the case. He argues that Dr. Remy Coeytaux violated 18 U.S.C. §§ 1461 and 1462, the federal Comstock Act, by knowingly using the mail to send abortion-inducing drugs from California to Texas. The suit also alleges Coeytaux committed felony murder under Texas Penal Code § 19.02 by knowingly aiding an illegal abortion. It cites multiple violations of Texas law, including statutes that require abortion drugs to be administered only by in-state physicians, after informed consent and a mandatory ultrasound, and only at licensed abortion facilities. Coeytaux, who is not licensed in Texas, allegedly met none of those requirements. The case is already being seen as a strategic test of blue state abortion shield laws. States like California, New York, and Washington have passed measures to protect their abortion providers from legal risks when treating out-of-state patients. But Rodriguez's legal team avoided those roadblocks by filing a civil wrongful death suit directly in federal court, a move some legal scholars say could offer a new route for anti-abortion plaintiffs to reach providers beyond their own state's borders. As of Friday, court records show Coeytaux had not filed a response to the complaint, and he has not made any public statements about the case. Pro-abortion groups are expected to contest both the interpretation of the Comstock Act and the standing of private citizens to bring wrongful death claims tied to out-of-state telehealth prescriptions. If the case survives early procedural hurdles, it may offer a new template for pro-life litigants to target the supply chain of abortion pills three years after Dobbs was decided at the Supreme Court. Coeytaux did not immediately respond to Fox News Digital's request for comment.
Associated Press
31 minutes ago
- Associated Press
Continuous glucose monitors are in vogue. But do you really need to track your blood sugar?
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, small patches that provide 24-hour insight into concentrations of sugar in the blood, could be a tool for Americans to 'take control over their own health,' Health Secretary Robert F. Kennedy Jr. recently told federal lawmakers. 'They can take responsibility,' Kennedy said. 'They can begin to make good judgments about their diet, about their physical activity, about the way they live their lives.' The devices have lifesaving benefits for people with diabetes, the disease caused when blood sugar remains high because their bodies don't make enough insulin or become resistant to it. The condition, which affects more than 38 million people in the U.S., raises the risk of serious health problems such as heart and kidney disease and vision loss. But the devices have surged in popularity among people without diabetes. Sales have been driven by high-profile marketers such as Casey Means, the nominee for U.S. surgeon general. There's scant evidence the monitors are useful for people with normal blood sugar levels, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Healthy bodies can effectively regulate glucose after meals and provide the energy they need to function. Glucose monitors may lead people to misinterpret normal swings in blood sugar that happen after eating or activity. In addition, the devices can be 'notoriously inaccurate,' providing misleading readings, she said. 'The problem with wearing these is that you can just be zooming in on and creating pathology when it's not there,' Dushay said. Here's what you need to know about the devices: Here's what a continuous glucose monitor does The device is a small patch, about the size of two stacked quarters, usually placed on the upper arm or stomach. It uses a needle to painlessly pierce the skin for a tiny sensor. The sensor measures the glucose in fluid under the skin, delivering a signal every few minutes to a phone app or a handheld display. The apps typically record blood sugar levels and help people track the foods they eat and how they impact those levels. When healthy people eat a meal that contains carbohydrates, their blood sugar rises, peaks and falls in response to the food. A healthy fasting blood glucose level for a person without diabetes is roughly 70 milligrams per deciliter to 99 milligrams per deciliter. A range from 100 to 126 milligrams per deciliter indicates prediabetes and above 126 milligrams per deciliter indicates diabetes, according to the American Diabetes Association. In adults without diabetes, blood sugar levels can climb to 140 milligrams per deciliter or more within an hour of a meal, before falling back to baseline levels within two or three hours, according to the association. It's a sign the body is processing sugar normally. Continuous glucose monitors have been available since the late 1990s For decades, these devices were available only for people with diabetes. The monitors revolutionized care by allowing more precise adjustment of insulin used to treat diabetes and giving people the ability to modify meals and activity more accurately. Last year, the U.S. Food and Drug Administration approved the first over-the-counter monitors. Since then, many companies have emerged to market them, claiming to provide intensive, individualized health monitoring. Cost is generally about $100 a month. They've really caught on with consumers curious about how food and activity affect their blood sugar levels. For instance, Noom, the weight-loss and fitness app, launched a blood glucose feature last year that has proven extremely popular, said Alexander Fabry, a company executive. 'Of the people who are using a CGM, the vast majority of them don't have a diabetes diagnosis,' he said. Who can use the monitors? The devices have been lifesaving for people with diabetes. And they can be helpful for people with risk factors for the disease, including obesity, prediabetes, a history of gestational diabetes or a family history of the condition. The devices can allow users to see how specific food and activity choices affect their blood sugar in near real-time, said Dr. Alaina Vidmar, a pediatric obesity specialist at Children's Hospital Los Angeles. 'After a large meal, you may watch your blood sugar go up and sort of learn something about yourself,' Vidmar said. 'For example, I drink a sugar-sweetened soda and my blood sugar goes up really high, really fast. And maybe I don't feel as good, right?' What are the cautions? People without risk factors for diabetes may turn to the monitors just because they're curious, said Dr. David Kessler. A former FDA commissioner, Kessler doesn't have diabetes, but he wore a monitor for a couple months during research for his recent book, 'Diet, Drugs and Dopamine.' 'I think it's a very interesting tool to experiment with if you're so inclined,' Kessler said. But, he noted, the devices can't be used to diagnose or treat disease. Even experts don't agree on how to interpret or provide health advice for people without diabetes based on blood sugar data. 'No one knows what's optimal in the nondiabetic state,' he said. Before using a monitor, Dushay asks patients to consider their motives. 'What do you think you're going to get from the data?' she said. 'What is to be gained from wearing that monitor?' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
